LiuWei Dihuang Wang (LDW), a traditional Chinese medicinal prescription, consists of dihuang (Rehmannia glutinosa LIBOSCH.), shanzhuyu (Cornus officinalis SIEB. et ZUCC.), shanyao (Dioscorea opposita THUNB.), zexie (Alisma orientalis (SAM.) JUZEP.), mudanpi (Paeonia suffruticosa ANDR.) and hoelen (Poria cocos (SCHW.) WOLF). It has long been employed in the clinical treatment of diabetic mellitus and neurosis, and is described as an anti-aging prescription in ancient Chinese herbal books. A recent pharmacological study revealed that LDW possesses anti-aging effects in vivo and in vitro [1] [2] [3] and possesses antioxidant and free radical scavenging activities.
Wei pointed out that LDW ameliorated the deterioration of learning and memory ability in senescent accelerated mice and hydrocortisone-treated mice. 6) Therefore, the ameliorating effects of LDW on memory ability are worthy of investigation.
Learning generates an experience-dependent and longlasting modification of the nervous system. It involves the activation, by neurotransmitters such as acetylcholine, dopamine and serotonin, of receptor-linked enzymes responsible for the synthesis of intercellular messages. 7, 8) A large number of studies have shown that the cholinergic system plays an important role in learning. 9) Scopolamine (SCOP), a cholinergic muscarinic antagonist, decreases cholinergic activity and impaired learning in rodents. 10, 11) The serotonergic system has also been implicated in learning, but a decrease in serotonergic activity facilitated acquisition. 12) p-Chloroamphetamine (PCA), a serotonergic releaser, increased serotonergic activity and impaired acquisition performance. 13) Therefore, SCOP-and PCA-induced amnesia appeared to be useful models for evaluating the action mechanisms of the cognition enhancers.
In the present study, we attempted to investigate the attenuating effects of LDW on SCOP-and PCA-induced amnesia by using the passive avoidance task and the facilitatory effects on active avoidance performance in rats. Moreover, the sensory, motivational or motor effects can alter acquisition and performance of the passive avoidance task. Therefore, alterations of motor activity of rats treated with LDW in the open field and passive avoidance task, and the hypnotic effects of LDW on pentobarbital-induced sleeping response, were demonstrated.
MATERIALS AND METHODS

Animals
Male Sprague-Dawley rats weighing 200-250 g and male ICR mice weighing 20-25 g were obtained from the Animal Center of the China Medical College and used in the following experiments according to the Guiding Principles for the Care and Use of Laboratory Animals. All rodents were housed for at least 1 week before starting the experiment in a temperature-(23Ϯ1°C) and humidity-(60%) regulated environment with free access to standard food in pellets (supplied and designed by Fwusow Industry Co. Ltd., Taiwan) and tap water, on a 12 h-12 h light/dark cycle (light phase: 08:00 to 20:00 h) was maintained. Then, the rats were randomly assigned into each group: passive avoidance performance, two-way active avoidance performance and motor activity measurement. Mice were only used in the pentobarbital-induced sleeping test. All behavioral assays were done using a double-blind method.
Materials LDW is composed of dihuang (Rehmannia glutinosa), shanzhuyu (Cornus officinalis), shanyao (Dioscorea opposita), zexie (Alisma orientalis), mudanpi (Paeonia suffruticosa) and hoelen (Poria cocos) in the ratio of 8 : 4 : 4 : 3 : 3 : 3 (dry weight). All components were bought from the market in Taiwan and authenticated by one of the authors. LDW (5 kg) was prepared as a mixture of all composed materials and extracted with distilled water, and the extract reduced to dryness with a vacuum rotary evaporator. The yield of the extract is 676 g (13.52%). LDW extract (0.1, 0.5, 1 and 2 g/kg) was applied in a distilled water solution (1 ml/kg body weight). SCOP hydrobromide and PCA were purchased from Sigma Chemical Co., and dissolved in 0.9% saline (1 ml/kg body weight). Pentobarbital sodium salt was purchased from Chriskev Company Inc., and dissolved in 0.9% saline (10 ml/kg body weight). The vehicle-treated rats received the same volume of saline.
Experimental Procedures For acute treatment, LDW was orally administered 1 h before the training trial of passive avoidance performance, pentobarbital-induced sleeping or pain sensitivity experiments. For chronic treatment, LDW was orally administered for one or two consecutive week, and all experiments exclusive of two-way active avoidance performance were carried out 1 h after the last dosage. Rats were administered LDW in combination with SCOP or PCA, used to induce amnesia. SCOP (1 mg/kg) and PCA (2.5 mg/kg) were intraperitoneally administered 30 min before the training trial. 14) In the two-way active avoidance performance, LDW was orally administered 1 h before or after the training trial.
Passive Avoidance Performance 15) The apparatus consisted of two compartments having a steel-rod grid floor (36 parallel steel rods, 0.3 cm in diameter set 1.5 cm apart). One of the compartments (48ϫ20ϫ30 cm) was equipped with a 20 W lamp located centrally at a height of 30 cm, and the other was a dark compartment of the same size, connected through a guillotine door (5ϫ5 cm). The dark room was used during the experimental sessions that were conducted between 09:00 and 17:00 h. On the training trial, the guillotine door between the light and dark compartment was closed. When each rat was placed in the light compartment with its back to the guillotine door, the door was opened, and simultaneously the time (step-through latency, STL) was measured with a stopwatch until the rat entered the dark compartment. After the rat entered the dark compartment, the door was closed. An inescapable scrambled footshock (1 mA for 2 s) was delivered through the grid floor. The rat was removed from the dark compartment 5 s after the shock. Then the rat was put back into the home cage until the retention trial. Twenty-four hours later, the retention trial was carried out. The rat was again placed in the light compartment and, as in the training trial, the guillotine door was opened and the step-through latency was recorded and used as a measure of retention. An upper cut-off time of 300 s was set.
Response of Unshocked Rats in the Passive Avoidance Task 15) Experimental steps were the same as that of the above section, but without the 1 mA footshock. Twenty-four hours later, the retention trial was carried out. The rat was again placed in the light compartment and, as in the training trial, the guillotine door was opened and the STL was recorded and used as a measure of retention.
Two-Way Active Avoidance Performance 16) The active avoidance test with negative reinforcement was performed in an automated passive/active avoidance computerized system (Columbus Instruments, Columbus, U.S.A.) consisting of two identical compartments measuring 48ϫ22.7ϫ27.3 cm and separated by a 7.7ϫ6.7 cm guillotine door. The floor of the two compartments was made from 37 electrified stainless-steel rods spaced 1 cm apart. Scrambled constant current shock (0.8 mA) was delivered through the grid floor and acted as an unconditioned stimulus (US). The conditioned stimulus (CS) consisted of a small lamp over the compartment occupied by the rat, and a tone generator (0.67 Hz) mounted over the center of the apparatus. Training and test sessions were performed between 13:00 and 17:00 h. Rats were trained to avoid US by moving to the other compartment in response to CS during training sessions that were performed 5 times per week. Each session consisted of 30 trials with an interval of 20 s between the start of each trial. A trial began with CS for a maximum period of 10 s. If the rat did not move to the other compartment during this period, US was delivered to the floor of the compartment containing the animal for a maximum period of 5 s. The test session was then performed 3 d later (i.e. on day 8). The parameters measured were: (1) number of avoidance responses when the rat moved to the other compartment during CS and (2) number of escape responses when the rat moved to the other compartment during US.
Motor Activity Measurement 17) An Opto-Varimex animal activity meter was used (Columbus Instruments International Co., Ltd., U.S.A.) for the measurements. The apparatus consisted of an acrylic activity monitor cage (43.2ϫ44.4ϫ 30.5 cm) which was surrounded by horizontal and vertical sensors that are non-detectable by rats. The apparatus also consisted of fifteen infrared beams spaced 2.65 cm apart on each axis. Two infrared beams were set as sensitivity monitors. The cage was enclosed in a ventilated cabinet. Measurements were performed between 09:00-17:00 h. Interruptions of photocell beams over a 5-min period were collected by a microcomputer, and activities such as grooming, scratching and digging were recorded.
Pentobarbital-Induced Hypnotic Test 18) Pentobarbital (40 mg/kg) was intraperitoneally administered to induce sleep. The interval between loss and recovery of the righting reflex was listed as the index of the hypnotic test.
Pain Threshold of Electric Stimulation Task
15)
The threshold of jump or vocalization produced by electric shock was measured using the passive avoidance apparatus. Each rat was placed in the dark compartment of the passive avoidance task apparatus and the shock intensity was manually raised stepwise from 0.5 to 1 mA in increments of 0.1 mA until either a flinch, jump or vocalization was observed. The duration of shock was 2 s, and the intershock interval was 15 s. The point at which the rat exhibited these responses was recorded.
Data Analysis All data of the passive avoidance performance were expressed with medians and interquartile ranges and analyzed using a Kruskal-Wallis non-parametric oneway analysis of variance, followed by Mann-Whitney's Utest. The criterion for statistical significance was pϽ0.05 in all statistical evaluations. All data of the two-way active avoidance performance were expressed with means and standard errors and analyzed using ANOVA analysis of variance for repeated measurements, followed by Dunnett's post-hoc tests for individual comparisons. The criterion for statistical significance was pϽ0.05 in all statistical evaluations. All data of the motor activity and pentobarbital-induced sleeping test were expressed with means and standard errors, and analyzed using ANOVA analysis of variance, followed by Scheff's test. The criterion for statistical significance was pϽ0.05 in all statistical evaluations.
RESULTS
Effects of LDW on SCOP-and PCA-Induced Amnesia
The STL of the SCOP-treated group was significantly shorter than that of the vehicle-treated group. The STL shortened by SCOP was significantly reversed by 2 g/kg LDW after single administration, 1 g/kg LDW after one-week consecutive administration, and 0.01-0.1 g/kg LDW after two-week consecutive administration (Fig. 1) . The STL of the PCA-treated group was significantly shorter than that of the vehicletreated group. The STL shortened by PCA was reversed by 2 g/kg LDW after single administration, 0.1-1 g/kg LDW after one-week consecutive administration, and 0.01-0.1 g/kg LDW after two-week consecutive administration (Fig.  1) .
Effects of LDW on the STL of the Training Trial in Non-shocked Rats The STL of the training trial in nonshocked rats, which were treated with LDW after single, oneweek or two-week duration, did not differ from that of the vehicle-treated rats (pϾ0.05) ( Table 1) . LDW plus either SCOP nor PCA had no effect on the STL of non-shocked rats (pϾ0.05) ( Table 1) .
Effects of LDW on Two-Way Active Avoidance Performance The rats treated with LDW only at 0.5 g/kg before or after each training session showed an increasing number of avoidances and a decreasing number of escapes on days 2-5 of learning when compared to the vehicle-treated rats. On the test session (day 8), the rats treated with LDW only at 0.5 g/kg before or after each training session also showed an increasing number of avoidances and a decreasing number of escapes when compared to the vehicle-treated rats (Figs. 2,  3) .
Effects of LDW on Motor Activity Ambulatory counts of vehicle-treated rats in a 5-min period were 1059.4Ϯ41.48. LDW at any dosage after single, one-week or two-week consecutive administration did not alter motor activity compared with the vehicle-treated rats (988.71Ϯ46.51 and 885.86Ϯ 47.57, 1047.86Ϯ40.91 and 907.5Ϯ66.06, 879Ϯ62.56 and 839.6Ϯ78.58, respectively). Table 2 , the onset and sleeping time induced by pentobarbital were not different among the rats treated with LDW after single, one-week or two-week consecutive administration and the vehicle-treated rats (pϾ0.05). 
Effects of LDW on Pentobarbital-Induced Hypnotic Test As shown in
Effects of LDW on Pain Sensitivity
DISCUSSION
The review of Decker and McGaugh has pointed out that the cholinergic neuronal system had a complementary effect with other neurotransmitters such as the serotonergic systems in the passive avoidance procedure and spatial memory paradigms. 19) Thus, SCOP and PCA were selected as drug-induced animal amnesia models for evaluating the action mechanisms of the cognition enhancers. In the present study, LDW at 2 but not 1 g/kg after single administration prolonged the STL shortened by SCOP or PCA. Therefore, we used one-tenth of the subthreshold dosage to evaluate the ameliorating effects of LDW for chronic administration in SCOP-or PCA-induced amnesia. For one-week consecutive administration, rats treated with 1 but not 0.1 g/kg LDW had longer STL than those treated with SCOP alone. Then the recovery from PCA-induced amnesia merely required from 0.1 to 1 g/kg. If LDW was given to rats for a longer time (two weeks), the used dosage that reversed from the STL shortened by SCOP or PCA was merely 0.01 g/kg. Therefore, we suggest that LDW possesses anti-amnesic activities. The potency of LDW after acute treatment is about ten times more than that after chronic treatment. We further demonstrated that the counteracting effects of LDW for single or one-week consecutive administration were mainly related to the central serotonergic system because the potency of recovery from PCA-induced amnesia was more than that of recovery from SCOP-induced amnesia. However, LDW at 0.1 g/kg for twoweek consecutive administration almost completely reversed amnesia induced by SCOP or PCA. Therefore, the counteracting effects of LDW for two-week consecutive administration were related to the central cholinergic and serotonergic systems. Furthermore, rats treated with LDW only at 0.5 but not 0.01-0.1 g/kg before or after each training session showed an increasing number of avoidances and a decreasing number of escapes on days 2-5 of learning when compared to the vehicle-treated rats. On day 8, LDW only at 0.5 g/kg administered before or after each training session also increased the number of avoidances and decreased number of escapes. We suggested that LDW possesses cognitive-en- hancing activities in terms of acquisition and memory consolidation of associative memory, but the required dosage is more than that in passive avoidance performance. According to the report of Zhou et al., LDW for single treatment potentiated long-term potentiation and synaptic plasticity in the hippocampus. 20) Therefore, the facilitating effects of LDW at 0.5 g/kg on the two-way active avoidance performance from day 2 might be related to the enhancement of neural communication by potentiating the long-term potentiation.
On the other hand, sensory, motivational or motor effects can alter acquisition and performance of the passive avoidance task. Therefore, alterations of motor activity of rats treated with LDW in the open field and passive avoidance task and the hypnotic effects of LDW on pentobarbital-induced sleeping time were demonstrated. In our present data, LDW alone after single, one-week or two-week consecutive treatment did not alter the STL in the training trial. The STL in the training trial of rats coadministered with LDW for single, one-week or two-week consecutive treatment and induced drugs was not different from those of rats treated with SCOP or PCA alone, although the STL for LDW at 0.1 g/kg after two-week consecutive treatment coadministered with SCOP was more than doubled. Furthermore, LDW alone after single, one-week or two-week consecutive treatment did not alter pain sensitivity compared with the vehicle-treated rats. Therefore, it appears that LDW after single, one-week or two-week consecutive treatment did not alter attention in the training trial of the passive avoidance test, but the attenuating effects of LDW at 0.1 g/kg after two-week consecutive treatment on SCOP-induced impairment might be partially related to the motor activity or attention caused by interaction with LDW and SCOP. Secondly, LDW at any dosage after single, one-week or two-week consecutive treatment did not affect the motor activity or pentobarbital-induced sleeping time in rodents. The data demonstrated that LDW after single, one-week or two-week consecutive treatment did not possess sedative/hypnotic or analgesic activity, and the beneficial effect of LDW on the impairment of passive avoidance performance induced by SCOP or PCA was due to its effects on memory-related processes. Moreover, drug activated liver microsomal enzymes may induce an enhancement of drug metabolism and accelerate the disappearance rate of SCOP, PCA and pentobarbital. An earlier report pointed out that LDW at 5 g/kg after one-week consecutive treatment could induce the activity of liver microsomal enzymes and shorten pentobarbital-induced sleeping time. 21) However, the dosage used in the present study is lower and did not alter the pentobarbital-induced sleeping time. Therefore, we suggest that the attenuating effects of LDW on SCOP-and PCA-induced passive avoidance performance impairment was not due to accelerating the disappearance rate of SCOP and PCA via activating liver microsomal enzymes.
From these above results, we suggest that LDW possesses anti-amnesic and cognitive-enhancing activities. These activities were parallel to treatment duration and dependent on the learning models. Furthermore, the major active component of LDW is mudanpi because mudanpi and its active ingredients, such as paeoniflorin, also ameliorated SCOP-induced amnesia. 22, 23) Moreover, the ameliorating effects of LDW on memory dysfunction might be due to increased cholinergic nervous activity and decreased serotonergic nervous activity. The interaction among the cholinergic system and other nervous systems in the ameliorating effects of LDW, and other components of LDW on memory ability will be worthy of investigation in the future.
